C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy
C2i Genomics, a cancer intelligence company, announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical...
Stay updated with breaking news from Nuprobe Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
C2i Genomics, a cancer intelligence company, announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical...
Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute’s DNA...
Spear Bio plans to use the technology to build a protein detection platform and an assay that can measure levels of neutralizing antibodies against SARS-CoV-2.
The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond...